Suppr超能文献

新型隐球菌A血清型菌株纯化及放射性碘化荚膜多糖与无荚膜突变体的结合

Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.

作者信息

Small J M, Mitchell T G

出版信息

Infect Immun. 1986 Dec;54(3):742-50. doi: 10.1128/iai.54.3.742-750.1986.

Abstract

Strains 6, 15, 98, 110, and 145 of Cryptococcus neoformans serotype A vary in capsule size, animal virulence, and susceptibility to in vitro phagocytosis. The isolated capsular polysaccharides (CPSs) differ in monosaccharide composition ratios and molecular size, as determined by gel filtration. The purpose of this investigation was to characterize the binding of CPSs to capsule-free mutants of C. neoformans and to examine CPSs from these strains for differences in their ability to bind, to determine whether such differences might explain the variation in the pathobiology of these strains. CPSs were partially periodate oxidized, tyraminated, iodinated with 125I, and used in binding studies with two capsule-free mutants of C. neoformans, strain 602 and Cap59. Binding was specific for yeast species and for polysaccharide and was saturable, which is consistent with a receptor-mediated mechanism of attachment. Binding occurred rapidly and was only slowly reversible. Binding was also independent of pH from pH 5.5 to 8, of cation concentrations, and of competition by sugars up to 1.0 M concentrations. Only a portion of CPS was capable of binding, and strains varied in the extent to which their CPS bound. CPS-15-IV (peak IV was the major polysaccharide peak on DEAE-cellulose chromatography of CPS from strain 15) had the highest proportion of binding (40%), followed by CPS from strains 98, 6, 145, 110, and 15-III (peak III was an earlier eluting fraction of CPS from strain 15). The CPSs differed similarly in their ability to competitively inhibit binding. Treatment of CPS, but not yeast cells, with proteinase XIV abolished binding without altering the CPS gross structure. Treatment of yeast cells with proteases, heat, or formaldehyde did not alter binding, and both strain 602 and Cap59 bound CPS similarly. Binding to encapsulated yeast cells was minimal.

摘要

新型隐球菌A血清型的6、15、98、110和145菌株在荚膜大小、动物毒力以及对体外吞噬作用的敏感性方面存在差异。通过凝胶过滤测定,分离出的荚膜多糖(CPS)在单糖组成比例和分子大小上有所不同。本研究的目的是表征CPS与新型隐球菌无荚膜突变体的结合情况,并检测这些菌株的CPS在结合能力上的差异,以确定这种差异是否可以解释这些菌株在病理生物学上的变化。CPS经部分高碘酸盐氧化、酪胺化、用125I碘化后,用于与新型隐球菌的两个无荚膜突变体602菌株和Cap59进行结合研究。结合对酵母种类和多糖具有特异性,且具有饱和性,这与受体介导的附着机制一致。结合迅速发生且仅缓慢可逆。结合也与pH值在5.5至8之间、阳离子浓度以及高达1.0 M浓度的糖的竞争无关。只有一部分CPS能够结合,且不同菌株的CPS结合程度不同。CPS - 15 - IV(峰IV是菌株15的CPS在DEAE - 纤维素色谱上的主要多糖峰)的结合比例最高(40%),其次是菌株98、6、145、110的CPS以及15 - III(峰III是菌株15的CPS较早洗脱的部分)。CPS在竞争抑制结合的能力方面也有类似差异。用蛋白酶XIV处理CPS而非酵母细胞可消除结合,且不改变CPS的总体结构。用蛋白酶、加热或甲醛处理酵母细胞不会改变结合,并且602菌株和Cap59对CPS的结合情况相似。与有荚膜酵母细胞的结合极少。

相似文献

2
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.
Infect Immun. 1989 Dec;57(12):3751-6. doi: 10.1128/iai.57.12.3751-3756.1989.
4
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
Infect Immun. 1984 Mar;43(3):879-86. doi: 10.1128/iai.43.3.879-886.1984.
6
Anti-chemotactic activity of capsular polysaccharide of Cryptococcus neoformans in vitro.
Microbiol Immunol. 1997;41(9):657-64. doi: 10.1111/j.1348-0421.1997.tb01908.x.
8
Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis.
Microbiol Immunol. 1994;38(11):851-6. doi: 10.1111/j.1348-0421.1994.tb02137.x.
9
Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture.
J Biol Chem. 2022 Apr;298(4):101769. doi: 10.1016/j.jbc.2022.101769. Epub 2022 Feb 24.

引用本文的文献

1
The Cryptococcus neoformans capsule: a sword and a shield.
Clin Microbiol Rev. 2012 Jul;25(3):387-408. doi: 10.1128/CMR.00001-12.
3
The outcome of phagocytic cell division with infectious cargo depends on single phagosome formation.
PLoS One. 2008 Sep 16;3(9):e3219. doi: 10.1371/journal.pone.0003219.
4
A yeast under cover: the capsule of Cryptococcus neoformans.
Eukaryot Cell. 2003 Aug;2(4):655-63. doi: 10.1128/EC.2.4.655-663.2003.
5
Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages.
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15245-50. doi: 10.1073/pnas.261418798. Epub 2001 Dec 11.
7
Tumor necrosis factor-inducing activities of Cryptococcus neoformans components.
Infect Immun. 1996 Dec;64(12):5199-204. doi: 10.1128/iai.64.12.5199-5204.1996.
8
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
Infect Immun. 1996 Aug;64(8):2897-903. doi: 10.1128/iai.64.8.2897-2903.1996.
9
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
Clin Microbiol Rev. 1995 Oct;8(4):515-48. doi: 10.1128/CMR.8.4.515.

本文引用的文献

2
Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases.
Am J Clin Pathol. 1955 Jan;25(1):14-24. doi: 10.1093/ajcp/25.1.14.
3
4
A radioimmunoassay for antibody to pneumococcal polysaccharides.
J Immunol Methods. 1982;49(1):83-8. doi: 10.1016/0022-1759(82)90368-4.
5
Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.
J Bacteriol. 1982 Jun;150(3):1292-6. doi: 10.1128/jb.150.3.1292-1296.1982.
6
Altered responsiveness of murine lymphoid cells treated with cryptococcal capsular polysaccharide.
Proc Soc Exp Biol Med. 1982 Apr;169(4):427-31. doi: 10.3181/00379727-169-41370.
9
Lipid on capsular polysaccharides of gram-negative bacteria.
J Biol Chem. 1981 Sep 10;256(17):8915-21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验